AARHUS, DENMARK, 6 June 2025: Cercare Medical, a leader in advanced neuroimaging software, is pleased to announce it has received additional regulatory clearance in South Korea for its Cercare Medical Neurosuite with Capillary Function, including its advanced perfusion imaging technology.
This milestone reinforces the company’s strategic commitment to expanding access to cutting-edge neuroimaging tools across Asia.
In addition to the regulatory approval, Cercare Medical is proud to welcome Korean Computer Motion ISG to its commercial program, joining Dynapex and further strengthening its market presence and reach in this important region.
"South Korea is a key market for advanced medical imaging, and this clearance—along with the expansion of our distributor network—demonstrates our continued growth and dedication to supporting clinicians globally," said Chief Commercial Officer Henrik Andersen.
Cercare Medical Neurosuite offers powerful, user-friendly tools for cerebral perfusion analysis, helping clinicians quickly assess capillary function and make informed decisions in time-sensitive environments like stroke and neurology care.
About Cercare Medical
Cercare Medical is a provider of advanced perfusion imaging solutions. With fully automated, vendor-neutral software for CT and MRI perfusion post-processing, the company supports clinicians across the world with tools that enhance diagnostics for stroke, oncology, Alzheimer’s disease, and other neurological conditions. Cercare’s proprietary biomarkers and automated pipelines enable better imaging maps, improving speed and confidence in clinical decision-making.
